Don’t distort enablement law, Amgen tells SCOTUS

09-03-2023

Muireann Bolger

Don’t distort enablement law, Amgen tells SCOTUS

Marlon Trottmann / Shutterstock.com

Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand.


Amgen, Sanofi, Regeneron, Supreme Court, enablement, patents, Repatha

LSIPR